BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Autoimmunity
,
Fluoxetine
,
rs3825942
,
NEUROG3
,
T cell differentiation
,
Breast Cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ethyl pyruvate
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Ethyl pyruvate treatment mitigates oxidative stress damage in cultured trabecular meshwork cells.
Ethyl pyruvate protects against lipopolysaccharide-induced white matter injury in the developing rat…
Ethyl pyruvate promotes spinal cord repair by ameliorating the glial microenvironment.
Ethyl pyruvate improves healing of colonic anastomosis in a rat model of peritonitis.
Ethyl pyruvate for the treatment of acetaminophen intoxication: alternative to N-acetylcysteine?
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts
CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulm…
Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer
Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammato…
Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ